
Our Pipeline
ProSeek Bio is partnering with stakeholders to develop blood tests for unmet diagnostic needs in women's health.
Please contact us with patient stories or partnering enquiries.

ProSeek Bio has commercialisation rights to biomarkers discovered by founder A/Prof Michelle Hill through an agreement with QIMR Berghofer Medical Research Institute. International partners identified for assay development and clinical studies for the indications of differential diagnosis of pelvic mass, screening of high-risk population including genetic risk and endometriosis.

Gynaecological Cancers
Partnering for biomarker discovery research.

Endometriosis and Autoimmune Conditions
Women are four times more likely to develop autoimmune conditions compared to men, and many suffered from medical gaslighting before eventual diagnosis. ProSeek Bio is seeking partners to change this narrative, by developing multi-biomarker blood tests for initial diagnosis of autoimmune conditions.